Stocks

AU Small Finance Bank stock gained 3.62% to an intraday high of Rs 1,007.25 on the NSE, marking its new 52-week peak.

Novo moves court to restrain Sun Pharma, Alkem from manufacture, sale of weight loss drug semaglutide

The fresh plea follows a recent court order allowing Dr. Reddy’s Laboratories (DRL) to continue manufacturing and exporting its version of semaglutide while prohibiting domestic sales until Novo Nordisk’s patent expires.

Zydus to enter US biosimilar market via Keytruda partnership with Germany's Formycon

The move is significant because Keytruda, one of the world’s top-selling immunotherapies with annual sales exceeding $20 billion, faces a looming patent expiry in 2028 in the US, opening the door for biosimilar competition in a market dominated by high-cost oncology drugs.

Small, midcap shares fall up to 12% amid profit booking; Kaynes Tech, Bharat Dynamics among top losers

Nifty Smallcap100 index declined for the fifth straight session, slipping over 3 percent in intra-day trade. The index has fallen more than 4 percent over the past five sessions.

Biocon to absorb biologics unit, eyes Rs 4,500 cr fund raise to buy Viatris’s residual stake

“When we created Biocon Biologics as a separate entity, the objective was clearly to attract investments and build global scale in biosimilars. We did that successfully, even acquiring Viatris’ biosimilars business for $3 billion. But markets kept devaluing both Biocon and Biocon Biologics because of debt overhang and holding company discount. Folding Biologics back into Biocon unlocks true value and gives us a much stronger balance sheet,” Mazumdar-Shaw said.

British American Tobacco sells 9% ITC Hotels stake for Rs 3,800 crore, retains 6.3% equity

Before the transaction, BAT was the second-largest shareholder in ITC Hotels, according to LSEG data.

Rate sensitive stocks rise: Realty, banks, others gain on RBI's 25 bps rate cut announcement

Nifty Realty was one of the top sectoral gainers, rising up to 1.3 percent, with eight of its 10 constituents trading higher.

Large trade deal: ITC Hotels shares trade flat as 9% equity worth Rs 3,856 crore changes hands; British American Tobacco likely seller

BAT planned to offload a stake worth about USD 776 million in ITC Hotels as part of efforts to reduce debt and exit a non-strategic asset.

IT stocks rise for 2nd day despite volatile market; Coforge, TCS lead gains: Here are three reasons why

Nifty IT is trading around 1.5 percent higher, after closing more than 1 percent higher on Wednesday.

Indian pharma eyes US biosimilars boom as USFDA eases rules

The US biosimilars market is projected to balloon from about $22.6 billion in 2025 to more than $90 billion by 2034, according to industry estimates.

IndiGo shares settle 2% lower as airline faces flight delays over tech issues

IndiGo has been facing acute crew shortage since the implementation of the second phase of the FDTL norms.

RPP Infra Projects shares rise 8% intraday on securing fresh order in Tamil Nadu

On the NSE, the stock rose 7.74 percent to an intraday high of Rs 115.61.

Delhi High Court allows Dr Reddy’s to make weight-loss drug for exports

The company, however, cannot sell the drug in the country till March 2026, when Novo Nordisk’s secondary patent expires

Wockhardt’s Zaynich NDA gets USFDA acceptance: What India’s first NCE means for the company

The next critical steps in the USFDA process involve a rigorous on-site evaluation: "visiting manufacturing facilities, inspecting documents, and so on".

“Very confident of positive outcome”: Habil Khorakiwala on USFDA acceptance of Wockhardt’s NDA for its novel antibiotic

Khorakiwala said the Mumbai-based drugmaker is already laying groundwork for commercialization, with options ranging from solo marketing to partnerships in the US.

Govt may sell nearly 5% stake in Bank of Maharashtra, reports CNBC-TV18; shares fall 2%

Public-sector banks have been in focus after Finance Minister Nirmala Sitharaman said last month that work had begun on the next phase of consolidation among state-run lenders.

Moneycontrol Pro Market Outlook | Surge in GDP a double-edged sword for Indian investors?

A slow and steady ascent has characterised the Nifty's third consecutive week of gains. Weak market breadth continues to unsettle investors, though the midcap index has bounced back

Cipla’s respiratory push: Sets up diagnostic centre in Delhi, Mumbai and other cities next

Cipla's wants to create awareness, help diagnostics, provide solutions and rehab support, COO Achin Gupta tells Moneycontrol, as the firm doubls down on its lung-care strategy

M&M shares rise 2% as Nomura finds new e-SUV priced attractively, sees up to 16% upside

Nomura maintained a ‘buy’ rating on M&M with a price target of Rs 4,355, a 16 percent upside from the current levels.

Rainbow Hospitals targets 3,165 beds by FY29, eyes high-birth North India as key growth engine

'North India is where the future demand lies, 60% of India’s 28.5 million annual births happen in UP, Bihar, Rajasthan and Haryana,' said Dr. Ramesh Kancharla, Chairman and MD in an interview to Moneycontrol

Tijori raises $5 million from Zerodha, to expand into enterprise segment

The company aims to have 70% of future products as enterprise-grade offerings because of the high cost of advanced AI queries

Nifty Auto index sees profit booking after hitting new record high; Eicher Motors, Bajaj Auto lead losses

Nifty Auto index had rallied more than 4 percent to 25,127.20 on August 18, 2025, after the GST cut announcement on August 15. From that level to Thursday’s record peak of 27,832.60, the index has gained 2,705.4 points or 10.76 percent.

Kotak Mahindra Bank board approves 5-for-1 stock split

Kotak Mahindra Bank said it seeks to make its shares more affordable and boost participation from retail investors.

M&M stock becomes top Nifty gainer as brokerages bullish on 'ambitious' growth targets

Emkay Global said electric vehicles remain central to M&M’s strategy, with a defined path to profitability.

Capital market index at fresh high as benchmark indices hit 52-week high; IEX, CAMS lead gains

Gains in the Nifty Capital market index were led by IEX, which settled 4.19% higher at Rs 142.86 per share on the NSE.